Phase II Nobex oral insulin results

Nobex ( Research Triangle Park, N.C.) and partner GlaxoSmithkline (GSK; LSE:GSK) said that in a U.S. Phase II trial in 31 patients with Type I diabetes, daily mealtime doses of Nobex's HIM2 (oral hexy...